Guerrino De Luca
Guerrino De Luca is an Italian-American business executive, best known for his role as the Executive Chairman of Logitech, a multinational technology company specializing in computer peripherals and software.
Early Life and Education[edit | edit source]
De Luca was born in Italy. He completed his undergraduate studies in Italy, earning a degree in Electronic Engineering. Further details about his early life and education are not widely available.
Career[edit | edit source]
De Luca began his career in the technology industry with Olivetti, an Italian manufacturer of computers, printers, and other business machines. He held various positions within the company, gaining experience in both technical and managerial roles.
In 1995, De Luca joined Apple, a multinational technology company known for its consumer electronics and software. He served as the President of Apple's product division, where he was responsible for the company's worldwide product marketing and business strategy.
In 1998, De Luca joined Logitech as President and CEO. Under his leadership, Logitech expanded its product portfolio and increased its global market share. He served as CEO until 2008, and then became the company's Executive Chairman, a position he holds to this day.
Personal Life[edit | edit source]
De Luca is known for his passion for technology and innovation. He is a strong advocate for the importance of design in technology products. He is also known for his leadership style, which emphasizes collaboration and open communication.
Recognition[edit | edit source]
De Luca's contributions to the technology industry have been recognized with several awards. In 2007, he was named "CEO of the Year" by CRN Magazine, a publication for technology industry professionals.
See Also[edit | edit source]
References[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD